Literature DB >> 2903220

Increased extrapyramidal symptoms with addition of lithium to neuroleptics.

G Addonizio1, S D Roth, P E Stokes, P M Stoll.   

Abstract

To explore whether lithium exacerbates neuroleptic-induced extrapyramidal symptoms (EPS), the authors prospectively rated 10 patients on neuroleptics before and after the addition of lithium. EPS ratings increased steadily after the initiation of lithium and were significantly elevated compared with baseline. Individual items that increased significantly were: gait, shoulder shaking, elbow rigidity, and tremor. These findings indicate that usual therapeutic levels of lithium may significantly worsen neuroleptic-induced EPS. Potential mechanisms for this interaction are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903220     DOI: 10.1097/00005053-198811000-00006

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  3 in total

1.  Incidence of adverse reactions to commonly prescribed psychopharmacological agents during early phase of therapy.

Authors:  A Kuruvilla; K Kuruvilla
Journal:  Indian J Psychiatry       Date:  1995-07       Impact factor: 1.759

2.  The effect of a therapeutic lithium level on a stroke-related cerebellar tremor.

Authors:  Rachel A Orleans; Marc J Dubin; Kristopher A Kast
Journal:  BMJ Case Rep       Date:  2018-01-24

Review 3.  Clinical relevance of drug interactions with lithium.

Authors:  P R Finley; M D Warner; C A Peabody
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.